128 related articles for article (PubMed ID: 2935550)
1. Specific and sensitive determination of medroxyprogesterone acetate in human serum by gas chromatography-mass spectrometry.
Dikkeschei LD; van Veelen H; Nagel GT; Willemse PH; Wolthers BG
J Chromatogr; 1985 Nov; 345(1):1-10. PubMed ID: 2935550
[TBL] [Abstract][Full Text] [Related]
2. Specific and sensitive quantitation of medroxyprogesterone acetate in human serum by gas chromatography-mass spectrometry.
Järvinen T; Keinonen T; Auriola S; Peura P; Hirvonen E; Palva E
J Chromatogr; 1989 Oct; 495():13-20. PubMed ID: 2533215
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer.
Kärkkäinen J; Vesterinen E; Stenman UH; Adlercreutz H; Nieminen U; Widholm O
Eur J Cancer; 1990; 26(9):975-7. PubMed ID: 2149024
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric and high-performance liquid chromatographic studies of medroxyprogesterone acetate metabolites in human plasma.
Sturm G; Häberlein H; Bauer T; Plaum T; Stalker DJ
J Chromatogr; 1991 Jan; 562(1-2):351-62. PubMed ID: 1827448
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.
Miller AA; Becher R; Schmidt CG
J Cancer Res Clin Oncol; 1988; 114(2):186-90. PubMed ID: 2965155
[TBL] [Abstract][Full Text] [Related]
6. Determination of megestrol acetate and cyproterone acetate in serum of patients with advanced breast cancer by high-performance liquid chromatography.
Dikkeschei LD; Wolthers BG; de Ruyter-Buitenhuis AW; Nagel GT; Sleijfer DT; Willemse PH; van der Slik W
J Chromatogr; 1990 Jul; 529(1):145-54. PubMed ID: 2145317
[TBL] [Abstract][Full Text] [Related]
7. Oral high-dose medroxyprogesterone acetate (MPA) treatment: cortisol/MPA serum profiles in relation to breast cancer regression.
Mahlke M; Grill HJ; Knapstein P; Wiegand U; Pollow K
Oncology; 1985; 42(3):144-9. PubMed ID: 4000617
[TBL] [Abstract][Full Text] [Related]
8. Medroxyprogesterone acetate does not perturb the profile of steroid metabolites in urine during pregnancy.
Yovich JL; Willcox DL; Wilkinson SP; Poletti VM; Hähnel R
J Endocrinol; 1985 Mar; 104(3):453-9. PubMed ID: 3156203
[TBL] [Abstract][Full Text] [Related]
9. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
Van Deijk WA; Blijham GH; Mellink WA; Meulenberg PM
Cancer Treat Rep; 1985 Jan; 69(1):85-90. PubMed ID: 3155651
[TBL] [Abstract][Full Text] [Related]
10. Medroxyprogesterone acetate in human serum.
Mathrubutham M; Fotherby K
J Steroid Biochem; 1981 Aug; 14(8):783-6. PubMed ID: 6457936
[TBL] [Abstract][Full Text] [Related]
11. Medroxyprogesterone acetate: variation in serum concentrations achieved with three commercially available preparations.
Stockdale AD; Chapman D; Mould GP; Rostom AY
Cancer Treat Rep; 1987 Sep; 71(9):813-5. PubMed ID: 2957052
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients.
Etienne MC; Milano G; Frenay M; Renee N; Francois E; Thyss A; Schneider M; Namer M
J Clin Oncol; 1992 Jul; 10(7):1176-82. PubMed ID: 1535103
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer.
Johnson JR; Priestman TJ; Fotherby K; Kelly KA; Priestman SG
Br J Cancer; 1984 Sep; 50(3):363-6. PubMed ID: 6235831
[TBL] [Abstract][Full Text] [Related]
14. Specific quantitation of plasma medroxyprogesterone acetate by gas chromatography/mass spectrometry.
Phillipou G; Frith RG
Clin Chim Acta; 1980 Apr; 103(2):129-33. PubMed ID: 6445243
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer.
Utaaker E; Lundgren S; Kvinnsland S; Aakvaag A
J Steroid Biochem; 1988 Oct; 31(4A):437-41. PubMed ID: 2971841
[TBL] [Abstract][Full Text] [Related]
16. Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate.
Halpenny O; Bye A; Cranny A; Feely J; Daly PA
Med Oncol Tumor Pharmacother; 1990; 7(4):241-7. PubMed ID: 2149401
[TBL] [Abstract][Full Text] [Related]
17. Simple high-performance liquid chromatographic method for the determination of medroxyprogesterone acetate in human plasma.
Read J; Mould G; Stevenson D
J Chromatogr; 1985 Jun; 341(2):437-44. PubMed ID: 3161906
[TBL] [Abstract][Full Text] [Related]
18. Control of illegal medroxyprogesterone acetate-application in veal calves by residue analysis in adipose tissue using HPLC/RIA methods.
Rapp M; Meyer HH
Food Addit Contam; 1989; 6(1):59-69. PubMed ID: 2521473
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of medroxyprogesterone acetate from three oral dosage formulations.
Stalker DJ; Welshman IR; Pollock SR
Clin Ther; 1992; 14(4):544-52. PubMed ID: 1388093
[TBL] [Abstract][Full Text] [Related]
20. Adrenal steroids as parameters of the bioavailability of MA and MPA.
Willemse PH; Dikkeschei LD; Tjabbes T; van Veelen H; Sleijfer DT
Eur J Cancer; 1990 Mar; 26(3):359-62. PubMed ID: 2141494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
